The work you do is changing lives. Across clinics, labs, and hospitals worldwide, clinicians and researchers share a common goal: to better understand the brain and improve care. At Welcony and across our family of TMS and EEG brands, our role is to support your commitment with trusted neurotechnology and partnership.
The research, stories and videos in this newsletter represent just a small glimpse of the hundreds of studies, treatments, and breakthroughs happening every year. This is your work in action. Together, we are shaping the future of brain health—and together, we are better.
Thank you for being part of this global community. We invite you to explore the stories below. Please email marketing@magstim.com so we can feature you!
Sincerely,
Ronnie Stolec-Campo
CEO, Welcony
his i
DECEMBER, 2025
INDONESIA TMS SYSTEM INSTALLATION
We’re pleased to share the successful installation of the Magstim Horizon 3.0 StimGuide Pro at General Hospital H. Adam Malik, Medan, Indonesia. A huge thank you to Pierce Lewis for completing the installation, and to our valued partner P.T Karindo for their continued collaboration and on-site support throughout the process.
EEG RESEARCH STUDY: Protocol to investigate neurophysiological link between resting-state brain activity and clinical symptoms in methamphetamine use disorder
Summary states, "The absence of reliable biomarkers impedes the objective diagnosis and monitoring of many psychiatric symptoms. Here, using cue-induced craving in methamphetamine use disorder as a case example, we present a protocol for linking neurophysiological characteristics to clinical symptoms through high-density electroencephalography (HD-EEG).
Thank you to Dr Thomas Hughes, for sharing this video review for Magstim TMS technology. We’re honored to build technology that supports your work, and grateful for your insights, leadership, and commitment to patient care. Dr Hughes is a highly respected psychiatrist and the founder of NeoPsych, an advanced mental health practice serving Los Angeles County, including Glendale, Burbank, Pasadena, and the surrounding areas.
EGI EEG AND MAGSTIM TMS FULLY INTEGRATED
NEW EGI GES 500
NEW HD-EEG system seamlessly integrates versatile hardware and software for EEG, TMS and other technologies, improving ease of use for new brain stimulation innovations. Built for future closed loop software integrations, AI and machine learning applications.
Thank you to the team at National Taiwan University Hospital and to Trushine for connecting Magstim TMS technology with physicians and hospitals in Taiwan. Magstim’s John Leedham just returned from a trip there to share insights on TMS technology for research and clinical applications.
As a global organization, Magstim is committed to supporting clinicians and researchers worldwide—advancing evidence-based care, knowledge sharing, and collaboration across borders to improve mental health outcomes.
VIDEO TMS Webinar System Workflow
NEW TMS live webinar video demonstrated the Magstim Horizon 3.0 with StimGuide Pro. This clinical transcranial magnetic stimulation (TMS) system is at work in clinics and practices helping to elevate patient care. Horizon 3.0 is FDA cleared for clinical treatment of MDD, OCD, Anxious Depression and Adolescent MDD. Learn the latest system updates and tips on coil location, treatments and more!
Evoked slow oscillations and dynamic network reorganization after stroke
Abstract states, "A focal ischemic lesion is thought to alter neuronal activity beyond the area of structural damage, thereby interfering with the whole network architecture. Here, we used a combination of transcranial magnetic stimulation and electroencephalography in conjunction with dynamic connectivity analyses and graph theory to study alterations and reorganization of cortical connectivity in a cohort of 41 patients longitudinally after stroke.
STAYING CONNECTED WITH DEVELOPMENTAL EEG RESEARCHERS: EGI HD-EEG at ISDP 2025.
Live EEG at the International Society for Developmental Psychobiology. Suhas VinchurkarTrey Avery shared the new EGI GES 500 HD-EEG intelligent eco-system for precision brain stimulation, discovery and advanced care. Up to 4,000 samples per second across 256 channels. This provides biomarker data for precision medicine and brain-computer interface.
TMS News Feature UToledo Health
ITMS In the News: UToledo Health adds another treatment option for major depression. Thank you to the team at UToledo Health and Spectrum News 1 for sharing this news story, highlighting the addition of TMS for patient care.
Thank you to Northeastern University for sharing this photo of the EGI Geodesic Sensor Net.
Caption states, "Seen around. Jonathan Peelle wears an electrode cap that records the electrical activity of the brain. Peelle is a director of the Speech, Hearing and Communication (SHAC) lab, located in ISEC. The lab uses a combination of behavioral testing and brain imaging to study how the brain supports communication, speech and auditory processing. Photo by Alyssa Stone/Northeastern University.
PAIN MEDICINE NEWS FEATURE:
FDA CLEARS MAGSTIM TMS FOR CHRONIC PAIN
Thank you to Pain Medicine News for sharing this news story. Chronic pain affects millions — and traditional therapies don’t always deliver effective relief. Now, there’s a proven, non-invasive, drug-free option for patients and clinicians alike: The Magstim Rapid, now FDA cleared for the treatment of chronic pain.* Using targeted magnetic stimulation, Magstim Rapid modulates neural pathways linked to pain — helping patients experience less pain, improved mobility, and a better quality of life.
The Magstim EGI Team demonstrated the new EGI GES 500 and the new Magstim Rapid TMS Systems at the Society for Neuroscience San Diego show.
OCTOBER, 2025
New TMS EEG Research: TMS-induced modulation of brain networks and its associations to rTMS treatment for depression: a concurrent fMRI-EEG-TMS as cited in Brain Stimulation Journal
Introduction states, "Transcranial magnetic stimulation (TMS) over the left dorsolateral prefrontal cortex (L-DLPFC) is an established intervention for treatment-resistant depression (TRD), yet the underlying therapeutic mechanisms remain not fully understood."
"Our study demonstrates that TMS acutely modulates connectivity within vital brain circuits, particularly the cognitive control and default mode networks. We found that the baseline TMS-evoked responses in the cognitive control and limbic networks significantly predicted clinical improvement in patients receiving a novel EEG-synchronized repetitive TMS treatment.
New EGI Blog and Video sharing the 256 Channel HD-EEG System Installation at Pontificia Universidad Católica de Chile. Dr Trey Avery, PhD, (EGI VP of Sales) returned from Chile after successfully installing the EGI System at Pontificia Universidad Católica de Chile (Campus Villarrica). This installation marks a significant milestone in expanding advanced neuroscience research infrastructure beyond the country’s metropolitan areas.
New EEG study: Noninvasive Biomarkers for Assessing the Excitatory/Inhibitory Imbalance in Children with Epilepsy
New research by Christos Papadelis in a post and that shared, "I am thrilled to share our new paper entitled "Noninvasive Biomarkers for Assessing the Excitatory/Inhibitory Imbalance in Children with Epilepsy" that was published in the Journal of Neuroscience." "In this paper, we noninvasively examine alterations in cortical rhythmic activity associated with pediatric hashtag#epilepsy using simultaneous high-density EEG MEG recordings during visual stimulation."
New TMS study: Longitudinal study of single-pulse TMS in infants with perinatal brain injury: safety and feasibility
Study states as posted in Frontiers: Introduction: Perinatal brain injury is a leading cause of cerebral palsy. Single-pulse transcranial magnetic stimulation (spTMS) provides a non-invasive method for investigating motor pathway development; however, data on the safety and feasibility of its repeated use in infants are limited. This study provides the first longitudinal evaluation of the safety, tolerability, and feasibility of spTMS in infants with perinatal brain injury.
Exciting LIVE video recording from the launch event for the new EGI Geodesic EEG System 500 (GES 500). The GES 500 HD-EEG system is a transformative new platform designed to advance brain research, precision stimulation, and our mission towards improving patient care.
As the global leader and gold standard in high-density EEG, EGI delivers unmatched signal quality and comfort. With the launch of the GES 500, we are redefining what’s possible in neuroscience by combining next-generation hardware with intelligent, intuitive software.
In this event, the EGI and Magstim teams share facts about this system. The GES 500 is more than an amplifier—it’s a platform. This system seamlessly integrates EEG with hashtag#TMS and other technologies, making it easier than ever to capture insights and innovate with brain stimulation. Its future-ready architecture supports closed-loop applications, AI, and machine learning integrations, creating new opportunities for breakthroughs in neuroscience.
The Magstim Team exhibited at the London TMS Course/The Academy of Brain Stimulation today. Thank you to Angharad Lewis, Derin Rose and Pierce Lewis who showcased the new Magstim Rapid and are shared insights on technology and treatments for transcranial magnetic stimulation Thank you the Academy of Brain Stimulation team and Alexander Sack for your commitment to educating the world in TMS
New TMS Research: Multi-Target Repetitive Transcranial Magnetic Stimulation Improves Freezing of Gait in Parkinson's Disease: A Randomized Controlled Trial
Objective-"In this randomized, double-blind, sham-controlled trial, we investigated the efficacy of multi-target 10-Hz rTMS targeting both M1 and SMA in alleviating freezing of gait (FOG) in Parkinson's disease (PD) patients."
Conclusions-"The results of this study indicate that bilateral M1 and SMA 10-Hz rTMS is a promising therapeutic approach, providing new possibilities for clinical treatment."
"Participants received real rTMS or sham rTMS for 10 consecutive days, administered by trained professionals. rTMS was delivered using the Magstim Rapid2 transcranial magnetic stimulation system, equipped with a 70-mm figure-eight coil."
New HD-EEG Article in Developmental Cognitive Neuroscience
“Age-related patterns of resting EEG power in infancy: Associations with prenatal socioeconomic disadvantage” Resting 128 channel HD-EEG power shows non-linear age-related patterns during the first 18 months of life. Prenatal family income-to-needs (ITN) moderates age-related patterns of theta and beta power.
EEG brain scans set to transform medicine. As brainwave test marks 100 years, experts look at what it's done, where it's headed
Article states, "The brainwave-reading technology of EEG helps monitor people with epilepsy and can detect when we're dozing off behind the wheel in a simulator. As scientists mark the 100th anniversary of the test, here's why many in the field are excited about its future uses in medicine."
Inspiring EEG research news from Bruce C Hansen Colgate University sharing how Brain-augmented AI reveals the neural dynamics behind perception.
Story states, "Hansen and his colleagues’ recent study, published in Nature’s Scientific Reports, uses a novel approach that combines human brain-wave recordings (electroencephalography or EEG) with a visual artificial intelligence (AI) model to answer the question: How does our intention shape how we perceive?"
Explore the enhanced capabilities of the new FDA-cleared Magstim Rapid TMS Research System in this on-demand webinar sharing the Rapid System Workflow & Research Applications.
See how the next-generation Rapid system improves workflow and performance—built for today’s neuroscience research.
Learn why Magstim Rapid is the most trusted and widely cited TMS platform in the world, with demonstrations and insights into real-world research applications.
NEW EGI ARTICLE: Advantages of High-Density EEG for training AI and ML models
As AI continues to rapidly accelerate applications for neuroscience research, the Magstim EGI team is here to support your work to study and treat the brain. we offer examples of how High-density EEG (HD-EEG) is the optimal tool for those interested in artificial intelligence and machine learning as it provides the data quality and resolution required to build accurate and robust models.
New exciting TMS video from iTalk TMS Kyle Hartfield shot at the Clinical TMS Society Annual Meeting San Diego. Big thank you to Kyle and his team for sharing his TMS treatment guided by Robert Rabinowitz and Mark Sejvar. Kyle is passionate about making more people aware of TMS and the benefits to treat patients with hashtag#depression, hashtag#OCD and adolescent MDD. The Magstim team is honored to be featured.
New TMS Study: Adaptive trial for the treatment of depressive symptoms associated with concussion using accelerated intermittent theta burst stimulation (ADEPT): rationale, design and methods
Study states: "Military service members (SMs) and veterans who have sustained one or more concussions during their service have significantly higher rates of persistent depressive symptoms and suicidality compared to non-injured peers."
Watch this Magstim TMS webinar recording with Stevie Foglia, PhD, McMaster University and CEO of Neuro-Mod Inc., and Aimee Nelson, PhD, McMaster University, to learn new research for rTMS for chronic pain management. Drs. Foglia and Nelson presented the latest results in chronic pain management using TMS.
This team shared insights on how practices throughout North America can get up and running.
New EEG Research: Distinct oscillatory mechanisms in low and high alpha-band activities for screening and potential treatment of Schizophrenia
Abstract states, "Schizophrenia (ScZ) is characterized by prominent perceptual abnormalities. A deeper understanding of the neural mechanisms underlying these abnormalities is crucial for developing precise treatment strategies. Resting-state EEG data from 55 ScZ patients and 61 healthy controls were analyzed to compare different sub-oscillations in the alpha band and their correlation with clinical symptoms (as measured by the general psychopathology scale)
In June, Magstim EGI was at the launch event of the brand-new Paediatric Mental Health Sciences Centre, a groundbreaking collaboration between UCL and the ICH Events - UCL GOS Institute of Child Health.
The event offers a deep dive into the Centre’s mission, along with insightful scientific talks focused on advancing mental health research in children EGI's European Sales Manager, Karen Wendt, showcased MagstimEGI innovative neuroimaging solutions—supporting the future of paediatric mental health research.
MAY, 2025
NEWS Announcement:
Magstim Granted EU MDR Certification
In May, Magstim Passed Compliance with Strict European Union Medical Device Regulations. Expanding Magstim Access to Entire EU Marketplace
Magstim has been granted EU MDR Certification for all transcranial magnetic stimulation (TMS) systems, demonstrating compliance with strict European Union Medical Device Regulations. This provides a path for Magstim TMS technology to be sold throughout the EU marketplace, and proves that the device is safe, clinically effective and has passed all requirements for testing and traceability.
SCIENCE FACTORY EEG TMS WORKSHOP FINLAND
Magstim EGI attended the 11th Science Factory TMS–EEG Workshop and Summer School in Espoo, Finland.
Hosted by the Department of Neuroscience and Biomedical Engineering at Aalto University. European Sales Manager, Karen Wendt, shared how EGI’s advanced EEG systems support your TMS–EEG studies.
TMS Research: Neuroprotective and plasticity promoting effects of repetitive transcranial magnetic stimulation (rTMS): A role for microglia
Abstract states, "Emerging evidence indicates that rTMS modulates microglial activation, promoting neuro-protective and plasticity-enhancing processes not only in models of brain disorders, such as Alzheimer’s and Parkinson’s disease, but also in healthy neural circuits."
NEW EEG STUDY: Neural mechanisms of spatial navigation in ASD and TD children: insights from EEG microstate and functional connectivity analysis
Study states, "Autism Spectrum Disorder (ASD) is associated with atypical neural dynamics, affecting spatial navigation and information integration. EEG microstates and functional connectivity (FC) are useful tools for investigating these differences. This study examines alterations in EEG microstates and theta-band FC during map-reading tasks in children with ASD (n = 12) compared to typically developing (TD) peers (n = 12), aiming to uncover neural mechanisms underlying spatial processing deficits in ASD."
Data were collected during a three-minute session using the Electrical Geodesics Inc. (EGI) EEG system
NEW TMS Study: Harnessing neuroimaging-guided transcranial magnetic stimulation for precision therapy in substance use disorders
Article states, "These studies demonstrate the potential of TMS as an extremely versatile and effective therapeutic intervention for SUDs when combined with neuroimaging techniques. By providing critical insights into structural integrity, functional connectivity, and activity patterns across key brain regions, neuroimaging allows for the identification of biomarkers and personalized targets, optimizing TMS protocols for maximum efficacy."
EEG STUDY POLAND: Recurrent and convolutional neural networks in classification of EEG signal for guided imagery and mental workload detection
Abstract states: "Guided Imagery technique is reported to be used by therapists all over the world in order to increase the comfort of patients suffering from a variety of disorders."
TMS News: FDA Clears Magstim TMS System for U.S. Adolescent Patient Treatment
Adolescent patients ages 15-21 can now receive non-invasive TMS for treatment of major depressive disorder (MDD). Major depression impacts more than 5 million U.S. adolescents every year, and NIH data shows that 20% of those aged 12 to 16 have had at least one major depressive episode*. The FDA has now cleared the Magstim Horizon 3.0 and Inspire Transcranial Magnetic Stimulation Systems for treating adolescent patients aged 15-21 for MDD, providing a non-invasive, non-pharmacological technology to improve care.
EEG Research: Learning to read transforms phonological into phonographic representations
Abstract states, "Learning to read changes the nature of speech representations. One possible change consists in transforming phonological representations into phonographic ones. However, evidence for such transformation remains surprisingly scarce. Here, we used a novel word learning paradigm to address this issue. During the learning phase, participants learned unknown words in both spoken and written forms. Following this phase, the impact of spelling knowledge on the auditory perception of the novel words was assessed at two time points through an unattended oddball paradigm, while the Mismatch Negativity component was measured by high density EEG."
TMS In The News: Innovative treatment helping Kitsap Mental Health address patients with severe depression
Thank you to the The Kitsap Sun for sharing this news from Kitsap Mental Health Servicesl. Inspiring news for patient treatments for depression. Story states, "About 62% of those patients have seen their symptoms of depression cut in half, including 48% who went into remission, meaning they are effectively no longer depressed."
Thank you to Jay Hughes and the team at Foundation for the Advancement of Clinical TMS (FACTMS)
Thank you to everyone for meeting and attending the 6th International Brain Stimulation Conference in Kobe, Japan. Brain Stimulation Journal Magstim EGI shared TMS, EEG and integrated neurotechnology solutions to study and treat the brain.
TMS RESEARCH NEWS TV FEATURE
Inspiring TMS Research TV news feature: UPMC-Pitt trial offers hope for patients with rare neurodegenerative diseases. The Magstim team is honored that University of Pittsburgh Medical Center UPMC is using this technology to advance care for patients with spinal muscular atrophy (SMA), a rare genetic disorder that affects motor neurons and can lead to paralysis and death.
This must watch inspiring news story shares researchers using TMS to study and treat patients.
We’re excited to share the successful installation of Horizon 3.0 at Bowmere Hospital, Countess of Chester Health Park, UK, part of the Cheshire and Wirral Partnership NHS Foundation Trust. Thank you to Jamie Robertson and Derin Rose for their excellent work on the installation, and to David Wilkinson for ensuring everything went smoothly as the Internal Auditor.
NEW EEG RESEARCH: Functional connectivity in burnout syndrome: a resting-state EEG study
Abstract states, "Chronic occupational stress is associated with a pronounced decline in emotional and cognitive functioning. Studies on neural mechanisms indicate significant changes in brain activity and changed patterns of event-related potentials in burnout subjects. This study presents an analysis of brain functional connectivity in a resting state, thus providing a deeper understanding of the mechanisms accompanying burnout syndrome."
EEG RESEARCH: Research hotspots and global trends in transcranial magnetic stimulation for stroke neurorestoration: A 30-year bibliometric analysis
Study states, "Stroke patients often experience various functional impairments. Transcranial magnetic stimulation (TMS) has emerged as a novel non-invasive brain stimulation technique, and has gained widespread attention over the past 30 years for its application in stroke. The present study used bibliometric and content analysis methods to explore the research hotspots and future trends of TMS in stroke, with an aim to provide benefits for subsequent research."
TMS In The News: Sleep Revolution: How Magnetic Pulses Could Treat Insomnia.
Thank you to University of Arizona College of Medicine - Phoenix and SciTechDaily for sharing.
Story states, "Researchers are developing a groundbreaking, non-medication approach to combat insomnia, particularly in military personnel. By using a novel brain stimulation technique that targets specific brain networks, the team led by William “Scott” Killgore aims to significantly enhance sleep quality and readiness in service members. Their promising initial results have led to a larger study to further validate and refine this technology."
EEG Study: Learning to read transforms phonological into phonographic representations
Abstract states, "Learning to read changes the nature of speech representations. One possible change consists in transforming phonological representations into phonographic ones. However, evidence for such transformation remains surprisingly scarce. Here, we used a novel word learning paradigm to address this issue. During the learning phase, participants learned unknown words in both spoken and written forms. Following this phase, the impact of spelling knowledge on the auditory perception of the novel words was assessed at two time points through an unattended oddball paradigm, while the Mismatch Negativity component was measured by high density EEG."
Contact info@magstimegi.com to learn more about Magstim EGI Imaging + Stimulation technologies.
We are inspired by your news and stories, please tell us more for a chance to be included in the next issue.
Thank you,
The Magstim & EGI Team
www.magstim.com
Please note: Magstim therapy systems are indicated for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Uses outside of this indication are considered investigational and may require an IDE and/or IRB.
Not all Magstim products are available in all territories. Please check with your Sales representative/Distributor.
